Skip to content

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-720%-204pp
Nuvation Bio logo
Nuvation BioNUVB
-105%-52.0pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-103.9%-43.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-0.1%-10.4pp
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-15.1%

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's operating margin?
Rigel Pharmaceuticals (RIGL) reported operating margin of 41.6% in Q1 2026.
How has Rigel Pharmaceuticals's operating margin changed year-over-year?
Rigel Pharmaceuticals's operating margin increased by 92.1% year-over-year, from 21.6% to 41.6%.
What is the long-term trend for Rigel Pharmaceuticals's operating margin?
Over 5 years (2020 to 2025), Rigel Pharmaceuticals's operating margin has grown at a 9.8% compound annual growth rate (CAGR), from -26.7% to 42.6%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.